Control | Exercise | |||||
---|---|---|---|---|---|---|
Pre (0 weeks) | Post (20 weeks) | Pre-post p-value | Pre (0 weeks) | Post (20 weeks) | Pre-post p-value | |
WBC (× 106/ml) (mlO2/min/kg) | 5.3 (4.2–6.5) | 5.0 (4.2–5.7) | 0.33 | 5.1 (4.3–6.1) | 4.7 (4.1–5.9) | 0.41 |
Neutrophils (× 106/ml) | 2.9 (2.3–4.0) | 2.9 (2.4–3.6) | 0.58 | 3.0 (2.6–3.7) | 2.9 (2.3–3.6) | 0.69 |
Lymphocytes (× 106/ml) | 1.6 (1.2–2.0) | 1.6 (1.1–1.9) | 0.31 | 1.7 (1.1–2.1) | 1.4 (1.1–1.9) | 0.19 |
% CD3 PBMC | 44 (37–53) | 45 (40–55) | 0.44 | 50 (40–63) | 47 (40–57) | 0.24 |
% CD4+ of CD3+ PBMC | 67 (51–78) | 63 (49–76) | 0.37 | 63 (53–77) | 63 (56–77) | 0.36 |
% CD8+ of CD3+ PBMC | 29 (16–39) | 32 (19–44) | 0.27 | 27 (17–41) | 29 (19–37) | 0.43 |
% CD19+ lymphocytes | 9.6 (7.5–16) | 11 (8.4–14) | 0.58 | 10 (6.1–13) | 9.6 (5.8–14) | 0.57 |
% MDSCs of PBMC | 1.7 (1.1–2.2) | 1.6 (1.2–2.7) | 0.38 | 2.2 (1.2–2.9) | 1.9 (1.1–3.3) | 0.88 |